vaccines and global health :: ethics and policy

….from the Center for Vaccine Ethics and Policy…GE2P2 Global Foundation

Menu

Skip to content

Home
about us
ethics & policy consulting
- CVEP: Fiduciary Transition [May-June 2015]
week in review
- #53112 (no title)
symposium resources
keynotes, papers, panels
- Observations and Comment :: Beware of Kingdoms bearing Gifts – Gavi, Yemen and $25 million from Saudi Arabia :: 3 Nov 2016

Molnupiravir — A Step toward Orally Bioavailable Therapies for Covid-19 R. Whitley

Posted on 14 February 2022 by davidrcurry

New England Journal of Medicine
February 10, 2022 Vol. 386 No. 6
https://www.nejm.org/toc/nejm/medical-journal

Editorials
Molnupiravir — A Step toward Orally Bioavailable Therapies for Covid-19 R. Whitley

Share this:

Facebook
X

Like Loading...

Related

This entry was posted in Uncategorized. Bookmark the permalink.

Post navigation

← Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico →

Search

Archives

Meta

Create account
Log in

Blog at WordPress.com.

Reblog
Subscribe Subscribed
- vaccines and global health :: ethics and policy
- Already have a WordPress.com account? Log in now.

%d